Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide in Adult Patients With Supratentorial Low Grade Glioma
NCT00313729Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- May 1999
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in low-grade glioma (LGG), sponsored by University of California, San Francisco. Started May 1999; status: completed.
02
Drugs
temozolomide
03
Conditions
low-grade glioma (LGG)
Beyond the preview
Go deeper on NCT00313729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313729.